[{"text": "Behaviour therapy versus doctor's anti-smoking advice in diabetic patients", "labels": [], "entities": []}, {"text": "Forty-four patients were randomized to Berger M (World Health Organization Collaborating a structured extensive behaviour therapy anti-Centre for Diabetes, Heinrich-Heine University, smoking intervention and 45 patients to a control Dusseldorf, Germany).", "labels": [], "entities": []}, {"text": "Behaviour therapy versus group that received a single unstructured anti-doctor's anti-smoking advice in diabetic patients.", "labels": [], "entities": []}, {"text": "smoking advice session given by a physician.", "labels": [], "entities": [{"text": "physician.", "start_pos": 34, "end_pos": 44, "type": "Health_Professional", "confidence": 0.6779413968324661}]}, {"text": "Journal of Internal Medicine 1993; 234: 4 0 7 4 0 9.", "labels": [], "entities": []}, {"text": "After 6 months, nine patients Sawicki PT, Didjurgeit U, Miilhauser I, Objectives.", "labels": [], "entities": []}, {"text": "To evaluate the efficacy of a structured behaviour therapy programme on smoking cessation in diabetic patients.", "labels": [], "entities": []}, {"text": "Prospective, randomized, controlled intervention study.", "labels": [], "entities": []}, {"text": "A total of 794 consecutive insulin-treated smoking diabetic patients were invited to participate were confirmed not to be smoking (i.e. urine cotinine concentration below 20 ng ml-', 2 [5%] in the behaviour therapy intervention group and 7 [ 16 %] in the control group.", "labels": [], "entities": [{"text": "urine cotinine", "start_pos": 136, "end_pos": 150, "type": "Biochemical_verification", "confidence": 0.7437563538551331}]}, {"text": "In diabetic patients an extensive behaviour therapy intervention for smoking cessation is no more successful than an unstructured physician's advice.", "labels": [], "entities": []}, {"text": "in a smoking cessation programme.", "labels": [], "entities": []}, {"text": "Eighty-nine Keywords: behaviour therapy, diabetes mellitus, patients agreed to participate and were randomized in two groups. smoking.", "labels": [], "entities": []}, {"text": "Cigarette smoking produces a variety of detrimental effects which are of special importance for diabetic patients [ 13.", "labels": [], "entities": []}, {"text": "It contributes to increased morbidity and mortality both in type 1 and type 2 diabetes . Stopping smoking reduces the risk of myocardial infarction in younger and older patients, decreases the incidence of strokes and reduces the risk of overall vascular morbidity and mortality.", "labels": [], "entities": []}, {"text": "Nevertheless, the prevalence of smokers amongst diabetic patients hardly differs from that of the general population [ 11.", "labels": [], "entities": []}, {"text": "Therefore, effective smoking cessation programmes seem particularly needed for diabetic patients.", "labels": [], "entities": []}, {"text": "In non-diabetic patients, cessation programmes have been reported to have a small, but important, positive effect or may even yield success rates of up to 45% over 1 year.", "labels": [], "entities": []}, {"text": "Minimal physician counselling has also been shown to be effective.", "labels": [], "entities": []}, {"text": "However, in diabetic patients even elaborate cess-27 ation programmes seem to be without any effect This study was designed to compare the effectiveness of a extensive behavioural anti-smoking programme with a physician's short session of antismoking advice.", "labels": [], "entities": []}, {"text": "From a diabetes department clinic, 2674 patients were asked about their smoking habits.", "labels": [], "entities": []}, {"text": "Out of this group 13% of type 2 diabetic patients and 29% of type 1 diabetic patients reported regular smoking of more than 5 cigarettes per day.", "labels": [], "entities": []}, {"text": "A total of 794 patients who were living within 100 km of the investigation centre were invited by mail to participate in a 'stop-smoking programme'.", "labels": [], "entities": [{"text": "794", "start_pos": 11, "end_pos": 14, "type": "Individual-level_analysed", "confidence": 0.612135112285614}, {"text": "patients", "start_pos": 15, "end_pos": 23, "type": "Aggregate_patient_role", "confidence": 0.8024230003356934}]}, {"text": "Out of this group 89 patients (1 1 %) agreed to participate and were randomized into an intervention group ( n = 44) and a control group ( n = 45).", "labels": [], "entities": []}, {"text": "For characteristics of the patients see.", "labels": [], "entities": []}, {"text": "The intervention group was offered a structured Characteristics at entry of all smoking diabetic patients who were invited to participate (total group)-the intervention group which was randomized to receive the behaviour therapy cessation programme, and control group which was to receive a single session of a physician's anti-smoking advice.", "labels": [], "entities": []}, {"text": "The number of confirmed non-smokers at the 6 - month follow-up after intervention is shown.", "labels": [], "entities": []}, {"text": "Values are given as means (standard deviations in parentheses.)", "labels": [], "entities": []}, {"text": "Intervention 37 10 23 8.5 (1.5)", "labels": [], "entities": []}, {"text": "There was no significant difference concerning any parameter between the groups.", "labels": [], "entities": []}, {"text": "behaviour therapy anti-smoking programme supervised by a specially educated psychotherapist.", "labels": [], "entities": []}, {"text": "This programme consists of 10 weekly sessions of 90 min each and aims at self-controlled reduction in nicotine intake.", "labels": [], "entities": []}, {"text": "The patients are encouraged to gradually decrease their number of cigarettes and stop smoking after the fifth session.", "labels": [], "entities": [{"text": "encouraged to gradually decrease their number of cigarettes", "start_pos": 17, "end_pos": 76, "type": "2.3_Self-monitoring_of_behavior", "confidence": 0.6692793071269989}]}, {"text": "A non-smoking contract has to be signed by each patient.", "labels": [], "entities": []}, {"text": "Non-smoking motivation is based on behaviour learning of how to begin cigarette reduction, discovering why you want to stop and why you have failed before, learning why you smoke, learning how to continue not to smoke and what support is available.", "labels": [], "entities": []}, {"text": "Relaxation techniques are included in the programme.", "labels": [], "entities": []}, {"text": "This structured behaviour progrmme is being used widely as a smoking cessation intervention in Germany and has been extensively described elsewhere [ 141.", "labels": [], "entities": [{"text": "smoking", "start_pos": 61, "end_pos": 68, "type": "Smoking", "confidence": 0.7327982187271118}, {"text": "Germany", "start_pos": 95, "end_pos": 102, "type": "Country_of_intervention", "confidence": 0.9762852787971497}]}, {"text": "The control group was to receive an unstructured nonsmoking advice session of about 1 5 min given by a physician in the diabetes out-patient clinic of the department.", "labels": [], "entities": []}, {"text": "In case of self-reported 'severe ' tobacco addiction, nicotine replacement (nicotine polacrilex gum) was offered to the patients.", "labels": [], "entities": []}, {"text": "All randomized patients were studied at baseline and re-investigated 6 months after intervention.", "labels": [], "entities": []}, {"text": "No patients were excluded or lost to follow-up.", "labels": [], "entities": []}, {"text": "Nonsmoking was assumed when at the 6 - month visit a patient self-reported not smoking and not using nicotine replacements and serum cotinine was below 20 ng ml-I.", "labels": [], "entities": [{"text": "serum cotinine", "start_pos": 127, "end_pos": 141, "type": "Biochemical_verification", "confidence": 0.744113028049469}]}, {"text": "Cotinine was measured in serum by a high-performance liquid chromatography (HPLC) method with the upper value for non-smokers being 20 ng ml-'.", "labels": [], "entities": []}, {"text": "Glycosylated haemoglobin values (HbAlc) were measured by an HPLC method, the normal range being 4.4 - 5.5 % of total haemoglobin.", "labels": [], "entities": []}, {"text": "The HbAlc values given in were measured at baseline before participation of the patients in a structured diabetes teaching and treatment programme.", "labels": [], "entities": []}, {"text": "Proteinuria was estimated by laser turbidimetry as described previously, the upper normal range of proteinuria being 6 0 mg 2 4 h-'.", "labels": [], "entities": []}, {"text": "For statistical analysis a two-tailed Student's t-test was performed, P-values below 0.05 were regarded as statistically significant.", "labels": [], "entities": []}, {"text": "In the group of 44 patients randomized into the behaviour therapy group, 2 5 (5 7%) participated in the programme.", "labels": [], "entities": []}, {"text": "Of the control group 3 1 patients (69 %) visited the out-patient clinic fora physician's anti-smoking advice.", "labels": [], "entities": []}, {"text": "During the behaviour therapy intervention the self-reported mean number of cigarettes smoked was reduced, being 2 1 cigarettes per day per patient (range: 5 4 0 cigarettes per day per patient) at the beginning of the programme and 5 cigarettes per day per patient (range: 0 - 17 cigarettes/day/patient) at the end of the programme.", "labels": [], "entities": []}, {"text": "However, at follow-up after 6 months, only 12 patients reported not smoking anymore (four in the intervention group and eight in the control group).", "labels": [], "entities": []}, {"text": "Of these patients, three had elevated serum cotinine concentrations (21 ng ml-' : 27 ng m1 - l: 101 ng ml-l).", "labels": [], "entities": []}, {"text": "Hence, two patients in the intervention group ( 5 %) and seven patients in the control group (1 6 %) were regarded as confirmed non-smokers at follow-up.", "labels": [], "entities": []}, {"text": "This difference between the groups is not statistically significant.", "labels": [], "entities": []}, {"text": "The results of this study show that smoking is frequent in type 1 and type 2 diabetic patients.", "labels": [], "entities": [{"text": "smoking", "start_pos": 36, "end_pos": 43, "type": "Smoking", "confidence": 0.7072767615318298}]}, {"text": "However, few smoking patients with diabetes are willing to participate in a smoking cessation programme.", "labels": [], "entities": []}, {"text": "Every third patient of those who initially stated to be willing to participate in an anti-smoking programme did not attend the meetings at all afterwards.", "labels": [], "entities": []}, {"text": "In diabetic patients willing to stop smoking, a widespread extensive structured behaviour therapy programme was no more effective than a short single session of a physician's advice.", "labels": [], "entities": []}, {"text": "Overall, the results of smoking cessation in both groups are disappointing.", "labels": [], "entities": [{"text": "smoking", "start_pos": 24, "end_pos": 31, "type": "Smoking", "confidence": 0.7887410521507263}]}, {"text": "However, approaches other than behaviour therapy techniques might be more effective, a hypothesis which remains to be tested in future controlled investigations.", "labels": [], "entities": []}, {"text": "In contrast to non-diabetic patients who make a serious attempt to stop smoking and amongst whom up to 45% may succeed, diabetic patients are less successful [12, 131.", "labels": [], "entities": []}, {"text": "The reasons for this difference between diabetic and non-diabetic smokers are not clear.", "labels": [], "entities": []}, {"text": "This study was not designed to clarify why the diabetic population maybe different.", "labels": [], "entities": []}, {"text": "However, one possible explanation is that depressive disorders occur more frequently in diabetic patients-when subjects with a history of depression stop smoking depressive symptoms may worsen.", "labels": [], "entities": []}, {"text": "Diabetic patients who, in some cases, are already psychologically adversely affected by the chronic nature of their disease, maybe less willing to accept a further impairment in their subjective perception of wellbeing associated with smoking cessation.", "labels": [], "entities": [{"text": "Diabetic", "start_pos": 0, "end_pos": 8, "type": "Aggregate_patient_role", "confidence": 0.3491601049900055}, {"text": "patients", "start_pos": 9, "end_pos": 17, "type": "Aggregate_patient_role", "confidence": 0.8600932359695435}]}, {"text": "In conclusion, smoking represents an important unsolved problem in the healthcare of diabetic patients.", "labels": [], "entities": []}, {"text": "To date for this group of patients, a doctor's comprehensive anti-smoking advice seems to be more reasonable than the implementation of complex behaviour modification programmes.", "labels": [], "entities": []}, {"text": "The Male patients (%) of Control: group has a value of 60.", "labels": [], "entities": []}, {"text": "The Type 1 diabetes (%) of Control: group has a value of 79.", "labels": [], "entities": []}, {"text": "The Patients with micro- or of Control: group has a value of 43.", "labels": [], "entities": []}, {"text": "The Age (years) of Control: group has a value of 37 (11).", "labels": [], "entities": []}, {"text": "The Diabetes duration (years) of Control: group has a value of 11 ( 8 ).", "labels": [], "entities": []}, {"text": "The Number of cigarettes per day of Control: group has a value of 21 (11).", "labels": [], "entities": []}, {"text": "The HbAlc (% total Hb) of Control: group has a value of 8.4 (2.0).", "labels": [], "entities": []}, {"text": "The Number of patients: 794 of Control: group has a value of 44.", "labels": [], "entities": []}, {"text": "The Male patients (%) of Control: group has a value of 59.", "labels": [], "entities": []}, {"text": "The Type 1 diabetes (%) of Control: group has a value of 80.", "labels": [], "entities": []}, {"text": "The Patients with micro- or of Control: group has a value of 32.", "labels": [], "entities": []}]